Eli Lilly and Co
NYSE:LLY

Watchlist Manager

Eli Lilly and Co

NYSE:LLY

Watchlist

Dividends

Price: 808.61 USD 0.18% Market Closed

Market Cap: 766.4B USD

Have any thoughts about
Eli Lilly and Co?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US	Johnson & Johnson NYSE:JNJ	Pharmaceuticals
US	Berkshire Hathaway Inc NYSE:BRK.A	Financial Services
US	Bank of America Corp NYSE:BAC	Banking
US	Mastercard Inc NYSE:MA	Technology
US	UnitedHealth Group Inc NYSE:UNH	Health Care
US	Exxon Mobil Corp NYSE:XOM	Energy
US	Pfizer Inc NYSE:PFE	Pharmaceuticals
US	Palantir Technologies Inc NYSE:PLTR	Technology
US	Nike Inc NYSE:NKE	Textiles, Apparel & Luxury Goods
US	Visa Inc NYSE:V	Technology
CN	Alibaba Group Holding Ltd NYSE:BABA	Retail
US	JPMorgan Chase & Co NYSE:JPM	Banking
US	Coca-Cola Co NYSE:KO	Beverages
US	Walmart Inc NYSE:WMT	Retail
US	Verizon Communications Inc NYSE:VZ	Telecommunication
US	Chevron Corp NYSE:CVX	Energy

Add Price Alert

Price Target:

Last Price: 808.61 USD

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching false

Delete

Cancel

LLY Alert

Eli Lilly and Co

808.61

+1.42 (+0.18%)

52 Week Range	713.71 958.4326
Price Target

We'll email you a reminder when the closing price reaches USD.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Johnson & Johnson NYSE:JNJ	US
	Berkshire Hathaway Inc NYSE:BRK.A	US
	Bank of America Corp NYSE:BAC	US
	Mastercard Inc NYSE:MA	US
	UnitedHealth Group Inc NYSE:UNH	US
	Exxon Mobil Corp NYSE:XOM	US
	Pfizer Inc NYSE:PFE	US
	Palantir Technologies Inc NYSE:PLTR	US
	Nike Inc NYSE:NKE	US
	Visa Inc NYSE:V	US
	Alibaba Group Holding Ltd NYSE:BABA	CN
	JPMorgan Chase & Co NYSE:JPM	US
	Coca-Cola Co NYSE:KO	US
	Walmart Inc NYSE:WMT	US
	Verizon Communications Inc NYSE:VZ	US
	Chevron Corp NYSE:CVX	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

Eli Lilly and Co

What unique competitive advantages
does Eli Lilly and Co hold over its rivals?

What risks and challenges
does Eli Lilly and Co face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of Eli Lilly and Co.

What unique competitive advantages
does Eli Lilly and Co hold over its rivals?

What risks and challenges
does Eli Lilly and Co face in the near future?

Has there been any significant insider trading activity
in Eli Lilly and Co recently?

Summarize the latest earnings call
of Eli Lilly and Co.

What significant events have occurred
in Eli Lilly and Co over the past months?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Eli Lilly and Co.

Provide P/S
for Eli Lilly and Co.

Provide P/E
for Eli Lilly and Co.

Provide P/OCF
for Eli Lilly and Co.

Provide P/FCFE
for Eli Lilly and Co.

Provide P/B
for Eli Lilly and Co.

Provide EV/S
for Eli Lilly and Co.

Provide EV/GP
for Eli Lilly and Co.

Provide EV/EBITDA
for Eli Lilly and Co.

Provide EV/EBIT
for Eli Lilly and Co.

Provide EV/OCF
for Eli Lilly and Co.

Provide EV/FCFF
for Eli Lilly and Co.

Provide EV/IC
for Eli Lilly and Co.

Show me price targets
for Eli Lilly and Co made by professional analysts.

What are the Revenue projections
for Eli Lilly and Co?

How accurate were the past Revenue estimates
for Eli Lilly and Co?

What are the Net Income projections
for Eli Lilly and Co?

How accurate were the past Net Income estimates
for Eli Lilly and Co?

What are the EPS projections
for Eli Lilly and Co?

How accurate were the past EPS estimates
for Eli Lilly and Co?

What are the EBIT projections
for Eli Lilly and Co?

How accurate were the past EBIT estimates
for Eli Lilly and Co?

Compare the revenue forecasts
for Eli Lilly and Co with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Eli Lilly and Co and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Eli Lilly and Co against its competitors.

Analyze the profit margins
(gross, operating, and net) of Eli Lilly and Co compared to its peers.

Compare the P/E ratios
of Eli Lilly and Co against its peers.

Discuss the investment returns and shareholder value creation
comparing Eli Lilly and Co with its peers.

Analyze the financial leverage
of Eli Lilly and Co compared to its main competitors.

Show all profitability ratios
for Eli Lilly and Co.

Provide ROE
for Eli Lilly and Co.

Provide ROA
for Eli Lilly and Co.

Provide ROIC
for Eli Lilly and Co.

Provide ROCE
for Eli Lilly and Co.

Provide Gross Margin
for Eli Lilly and Co.

Provide Operating Margin
for Eli Lilly and Co.

Provide Net Margin
for Eli Lilly and Co.

Provide FCF Margin
for Eli Lilly and Co.

Show all solvency ratios
for Eli Lilly and Co.

Provide D/E Ratio
for Eli Lilly and Co.

Provide D/A Ratio
for Eli Lilly and Co.

Provide Interest Coverage Ratio
for Eli Lilly and Co.

Provide Altman Z-Score Ratio
for Eli Lilly and Co.

Provide Quick Ratio
for Eli Lilly and Co.

Provide Current Ratio
for Eli Lilly and Co.

Provide Cash Ratio
for Eli Lilly and Co.

What is the historical Revenue growth
over the last 5 years for Eli Lilly and Co?

What is the historical Net Income growth
over the last 5 years for Eli Lilly and Co?

What is the current Free Cash Flow
of Eli Lilly and Co?

Discuss the annual earnings per share (EPS)
trend over the past five years for Eli Lilly and Co.

EV/EBIT
Enterprise Value to EBIT

40.4

Current

54.1

Median

16.3

Industry

Lower than median

Higher than industry value

Enterprise Value to EBIT (EV/EBIT) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s earnings before interest and taxes (EBIT). Considered one of the most frequently used multiples for comparisons among companies, the EV/EBIT multiple relies on operating income as the core driver of valuation.

EV/EBIT

40.4

Enterprise Value

797.6B USD

EBIT

19.7B USD

All Countries

All Countries United States of America United Kingdom Canada New Zealand Germany Bermuda Ireland Luxembourg Austria Italy France Belgium Netherlands Portugal Switzerland Spain Lithuania Estonia Latvia Finland Iceland Sweden Norway Denmark Israel Hong Kong Korea Poland Hungary Philippines Singapore India Japan Pakistan Australia Chile Saudi Arabia Thailand China Indonesia Greece South Africa Vietnam Malaysia Brazil Argentina Mexico Croatia Turkey Taiwan Peru Russia Cyprus Cayman Islands Papua New Guinea Mongolia Guernsey British Virgin Islands Panama Puerto Rico Monaco Colombia Uruguay United Arab Emirates Macao Egypt Bahamas Jersey Anguilla Nicaragua Isle of Man Mauritius Guam Venezuela Czech Republic Malta Liechtenstein Georgia Cambodia Azerbaijan Ukraine French Guiana Martinique Costa Rica Gibraltar Morocco Virgin Islands (U.S.) Faroe Islands Nigeria Bulgaria Slovenia Slovakia Romania Kazakhstan Jordan Kenya Zimbabwe Malawi

Forward Multiples

			Market Cap	EV/EBIT
US		Eli Lilly and Co NYSE:LLY	766.3B USD	40.4
UK		Dechra Pharmaceuticals PLC LSE:DPH	440.4B GBP	17 702.3
US		Johnson & Johnson NYSE:JNJ	373.5B USD	16.4
DK		Novo Nordisk A/S CSE:NOVO B	2.3T DKK	17.4
CH		Roche Holding AG SIX:ROG	214.7B CHF	11.4
CH		Novartis AG SIX:NOVN	190B CHF	14.3
UK		AstraZeneca PLC LSE:AZN	169.1B GBP	198.7
US		Merck & Co Inc NYSE:MRK	202.1B USD	10.5
IE	E	Endo International PLC LSE:0Y5F	163.5B USD	655.3
US		Pfizer Inc NYSE:PFE	139.2B USD	10.6
FR		Sanofi SA PAR:SAN	108.7B EUR	5.6

				EBIT Growth	EV/EBIT to Growth
US		Eli Lilly and Co NYSE:LLY	Average EV/EBIT: 1 698.4 40.4	32%	1.3
UK		Dechra Pharmaceuticals PLC LSE:DPH	17 702.3	98%	180.6
US		Johnson & Johnson NYSE:JNJ	16.4	13%	1.3
DK		Novo Nordisk A/S CSE:NOVO B	17.4	14%	1.2
CH		Roche Holding AG SIX:ROG	11.4	6%	1.9
CH		Novartis AG SIX:NOVN	14.3	10%	1.4
UK		AstraZeneca PLC LSE:AZN	198.7	23%	8.6
US		Merck & Co Inc NYSE:MRK	10.5	11%	1
IE	E	Endo International PLC LSE:0Y5F	655.3	N/A	N/A
US		Pfizer Inc NYSE:PFE	10.6	10%	1.1
FR		Sanofi SA PAR:SAN	5.6	14%	0.4

EV/EBIT Forward Multiples

Forward EV/EBIT multiple is a version of the EV/EBIT ratio that uses forecasted EBIT for the EV/EBIT calculation. 1-Year, 2-Years, and 3-Years forwards use EBIT forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward

EV/EBIT

2-Years Forward

EV/EBIT

24.9

3-Years Forward

EV/EBIT

20.2

	Cerus Corp NASDAQ:CERS	1.42 USD -1.39%
	Tilray Brands Inc NASDAQ:TLRY	0.4258 USD 1.45%
I	Ibersol SGPS SA ELI:IBS	9.86 EUR -1.4%

	Franklin Covey Co NYSE:FC	22.61 USD -2.08%
	Mohawk Industries Inc NYSE:MHK	104.71 USD -1.16%
	Ardmore Shipping Corp NYSE:ASC	9.82 USD 1.97%
	ASGN Inc NYSE:ASGN	53.46 USD -2.73%
	Skyworks Solutions Inc NASDAQ:SWKS	72.82 USD -2.84%
	Weatherford International PLC NASDAQ:WFRD	52.26 USD 1.67%

	Johnson & Johnson NYSE:JNJ	155.26 USD -0.76%
	Bank of America Corp NYSE:BAC	44.73 USD -0.8%
	Mastercard Inc NYSE:MA	590.74 USD 0.2%
	Salesforce Inc NYSE:CRM	265.91 USD -0.86%
	Abbvie Inc NYSE:ABBV	191.5 USD 1.06%
	Home Depot Inc NYSE:HD	360.46 USD -2.02%

	Arista Networks Inc NYSE:ANET	94.21 USD 0.54%
	Deckers Outdoor Corp NYSE:DECK	107.93 USD -1.88%
	Visa Inc NYSE:V	373.31 USD 0.7%
	Texas Pacific Land Corp NYSE:TPL	1 100.01 USD 0.04%
	KLA Corp NASDAQ:KLAC	872 USD 1.8%
	Manhattan Associates Inc NASDAQ:MANH	189.33 USD -2.04%

	Salesforce Inc NYSE:CRM	265.91 USD -0.86%
	Accenture PLC NYSE:ACN	319.22 USD -0.53%
	ServiceNow Inc NYSE:NOW	1 004.33 USD -0.54%
	Spotify Technology SA NYSE:SPOT	709.14 USD 2.28%
	EOG Resources Inc NYSE:EOG	119.92 USD 1.73%
	Applied Materials Inc NASDAQ:AMAT	172.79 USD -0.56%

Eli Lilly and Co
NYSE:LLY

EV/EBIT
Enterprise Value to EBIT

EV/EBIT Forward Multiples

See Also

Company

Help

Tools

Stocks

Eli Lilly and Co NYSE:LLY

EV/EBIT Enterprise Value to EBIT

EV/EBIT Forward Multiples

See Also

Company

Help

Tools

Stocks

Eli Lilly and Co
NYSE:LLY

EV/EBIT
Enterprise Value to EBIT